Literature DB >> 6629332

The X-ray crystal structure analysis of the refined complex formed by bovine trypsin and p-amidinophenylpyruvate at 1.4 A resolution.

J Walter, W Bode.   

Abstract

The X-ray crystal structure of the complex formed by bovine beta-trypsin and the potent small inhibitor p-amidinophenylpyruvate at pH 7.6, has been determined by difference Fourier methods at 1.4 A resolution and subsequently refined to a crystallographic R value of 0.191, applying diagonal matrix least-squares procedures including energy constraints. The amidino and the phenyl group of this inhibitor are bound to the specificity pocket, essentially as previously observed in benzamidine-trypsin. The reactive Ser195 O gamma of trypsin forms a covalent bond of length 1.7 A to the carbonyl carbon of the pyruvate group. The hybridization of this carbonyl carbon is just between trigonal and tetrahedral. The imidazole ring of His57 is in a correct orientation to form bonds via its N epsilon 2 hydrogen to one of the carboxylate oxygens of p-amidinophenylpyruvate and to Ser195 O gamma. The probable proton shift makes Ser195 O gamma more nucleophilic and the attacked carbonyl carbon of p-amidinophenylpyruvate more electrophilic and thus facilitates bond formation. These specific interactions offer a qualitative explanation for the unique binding properties of p-amidinophenylpyruvate and for the applicability of the quantitative structure-activity relations previously found by Markwardt and coworkers for three series of p-amidinophenylalkanone compounds with carbonyl groups in alpha-, beta- and gamma-position to the phenyl ring.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6629332     DOI: 10.1515/bchm2.1983.364.2.949

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  8 in total

1.  The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.

Authors:  C P Sommerhoff; W Bode; P J Pereira; M T Stubbs; J Stürzebecher; G P Piechottka; G Matschiner; A Bergner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.

Authors:  G Barbato; D O Cicero; F Cordier; F Narjes; B Gerlach; S Sambucini; S Grzesiek; V G Matassa; R De Francesco; R Bazzo
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

3.  Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335.

Authors:  Christopher T Lemke; Nathalie Goudreau; Songping Zhao; Oliver Hucke; Diane Thibeault; Montse Llinàs-Brunet; Peter W White
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

Review 4.  Antibodies as defensive enzymes.

Authors:  Sudhir Paul; Yasuhiro Nishiyama; Stephanie Planque; Sangeeta Karle; Hiroaki Taguchi; Carl Hanson; Marc E Weksler
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

5.  Crystallization and preliminary X-ray analysis of a protease inhibitor from the latex of Carica papaya.

Authors:  Mohamed Azarkan; Abel Garcia-Pino; Rachid Dibiani; Lode Wyns; Remy Loris; Danielle Baeyens-Volant
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-30

6.  Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping.

Authors:  D Suckau; J Köhl; G Karwath; K Schneider; M Casaretto; D Bitter-Suermann; M Przybylski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.

Authors:  Stephanie Planque; Miguel A Escobar; Keri C Smith; Hiroaki Taguchi; Yasuhiro Nishiyama; Elizabeth Donnachie; Kathleen P Pratt; Sudhir Paul
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

8.  Antibody catalysis of peptidyl-prolyl cis-trans isomerization in the folding of RNase T1.

Authors:  L Ma; L C Hsieh-Wilson; P G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.